Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹8,218 Cr
Revenue (TTM)
₹2,478 Cr
Net Profit (TTM)
₹19 Cr
ROE
5.7 %
ROCE
12.4 %
P/E Ratio
433.6
P/B Ratio
6.1
Industry P/E
44.5
EV/EBITDA
19
Div. Yield
0 %
Debt to Equity
1.1
Book Value
₹89.6
EPS
₹2.8
Face value
10
Shares outstanding
149,302,204
CFO
₹1,684.86 Cr
EBITDA
₹1,938.97 Cr
Net Profit
₹-188.49 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| -17.0 | -7.9 | -21.3 | 10.2 | 27.4 | 25.9 | -- |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| 36.5 | 33.9 | 27.2 | 20.2 | 45.5 | 56.1 | -46.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Healthcare Global
|
546.4 | 8,217.6 | 2,478.2 | 24.7 | 8.4 | 4.2 | 433.6 | 6.1 |
| 229.2 | 3,624.4 | 1,041.9 | 96.4 | 12.0 | 11.5 | 37.5 | 3.1 | |
| 636.2 | 32,981.0 | 4,461.2 | 397.5 | 13.4 | 9.1 | 100.9 | 7.2 | |
| 423.5 | 13,410.5 | 1,976.2 | 160.7 | 14.1 | 6.7 | 106.4 | 6.8 | |
| 4,726.4 | 2,284.2 | 450.7 | 69.9 | 22.1 | 26.7 | 32.7 | 6.9 | |
| 390.7 | 3,582.6 | 1,451.5 | 182.9 | 15.5 | 29.2 | 19.6 | 5.1 | |
| 1,282.7 | 8,399.0 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.5 | 5.6 | |
| 5,249.4 | 5,744.0 | 1,529.9 | 235.8 | 21.2 | 20.7 | 24.4 | 4.6 | |
| 1,103.8 | 11,233.0 | 1,613.3 | 259.9 | 23.0 | 17.3 | 43.6 | 7.1 | |
| 649.5 | 6,262.6 | 1,089.4 | 165.1 | 17.4 | 10.2 | 37.4 | 3.6 |
1 min read•By Research Desk
How did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through... radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and outpatients treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. In addition, the company offers cancer diagnostic services; combining laboratory services; and research and development, and clinical research to enhance cancer diagnosis and prognosis. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India. Read more
Incorporated
1998
Chairman
B S Ajai Kumar
Managing Director
--
Group
HCG
Headquarters
Bengaluru, Karnataka
Website
Looking for more details about Healthcare Global Enterprises Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Healthcare Global Enterprises Ltd is ₹546.40 (NSE) and ₹550.40 (BSE) as of 19-Mar-2026 IST. Healthcare Global Enterprises Ltd has given a return of 27.36% in the last 3 years.
The P/E ratio of Healthcare Global Enterprises Ltd is 433.65 times as on 19-Mar-2026, a 874 premium to its peers’ median range of 44.50 times.
The P/B ratio of Healthcare Global Enterprises Ltd is 6.14 times as on 19-Mar-2026, a 7 discount to its peers’ median range of 6.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
168.91
|
8.33
|
|
2024
|
97.83
|
5.83
|
|
2023
|
124.52
|
4.31
|
|
2022
|
69.83
|
4.34
|
|
2021
|
0.00
|
3.70
|
The 52-week high and low of Healthcare Global Enterprises Ltd are Rs 799.71 and Rs 492.51 as of 20-Mar-2026.
Healthcare Global Enterprises Ltd has a market capitalisation of ₹ 8,218 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Healthcare Global Enterprises Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-23.60
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.